Literature DB >> 15498674

Synthesis and biological evaluation of some 6-arylamidomorphines as analogues of morphine-6-glucuronide.

James M Macdougall1, Xiao-Dong Zhang, Willma E Polgar, Taline V Khroyan, Lawrence Toll, John R Cashman.   

Abstract

A series of 6-beta-arylamidomorphines was synthesized and biologically evaluated. Various aryl substituents were introduced into the arylamidomorphines to examine substituent structure-activity relationships. Competition binding assays showed that compounds 10a-h bound to the mu opioid receptor with high affinity (0.2-0.6 nM). Functional assays showed that compounds 10a-h acted as full mu opioid receptor agonists. The ED(50) of compound 10e.HCl as an analgesic was 12.6 mg/kg in the tail flick latency test in the rat.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15498674     DOI: 10.1016/j.bmc.2004.08.019

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

1.  Synthesis and evaluation of aryl-naloxamide opiate analgesics targeting truncated exon 11-associated μ opioid receptor (MOR-1) splice variants.

Authors:  Susruta Majumdar; Joan Subrath; Valerie Le Rouzic; Lisa Polikar; Maxim Burgman; Kuni Nagakura; Julie Ocampo; Nathan Haselton; Anna R Pasternak; Steven Grinnell; Ying-Xian Pan; Gavril W Pasternak
Journal:  J Med Chem       Date:  2012-07-16       Impact factor: 7.446

2.  Efficacy, but not antibody titer or affinity, of a heroin hapten conjugate vaccine correlates with increasing hapten densities on tetanus toxoid, but not on CRM197 carriers.

Authors:  Rashmi Jalah; Oscar B Torres; Alexander V Mayorov; Fuying Li; Joshua F G Antoline; Arthur E Jacobson; Kenner C Rice; Jeffrey R Deschamps; Zoltan Beck; Carl R Alving; Gary R Matyas
Journal:  Bioconjug Chem       Date:  2015-06-05       Impact factor: 4.774

3.  Synthesis and characterization of a dual kappa-delta opioid receptor agonist analgesic blocking cocaine reward behavior.

Authors:  András Váradi; Gina F Marrone; Shainnel O Eans; Michelle L Ganno; Joan J Subrath; Valerie Le Rouzic; Amanda Hunkele; Gavril W Pasternak; Jay P McLaughlin; Susruta Majumdar
Journal:  ACS Chem Neurosci       Date:  2015-09-14       Impact factor: 4.418

4.  Novel 6β-acylaminomorphinans with analgesic activity.

Authors:  András Váradi; Sándor Hosztafi; Valerie Le Rouzic; Gergő Tóth; Ákos Urai; Béla Noszál; Gavril W Pasternak; Steven G Grinnell; Susruta Majumdar
Journal:  Eur J Med Chem       Date:  2013-09-22       Impact factor: 6.514

5.  Insights into subtype selectivity of opioid agonists by ligand-based and structure-based methods.

Authors:  Jianxin Cheng; Guixia Liu; Jing Zhang; Zhejun Xu; Yun Tang
Journal:  J Mol Model       Date:  2010-05-25       Impact factor: 1.810

6.  Synthesis and pharmacological evaluation of novel selective MOR agonist 6β-pyridinyl amidomorphines exhibiting long-lasting antinociception.

Authors:  Ákos Urai; András Váradi; Levente Szőcs; Balázs Komjáti; Valerie Le Rouzic; Amanda Hunkele; Gavril W Pasternak; Susruta Majumdar; Sándor Hosztafi
Journal:  Medchemcomm       Date:  2016-10-18       Impact factor: 3.597

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.